Skip to main content
Premium Trial:

Request an Annual Quote

Financial Times: New Lion Contract to Trump Bayer Deal

Premium

Last week, Lion CEO Friedrich von Bolen told the Financial Times Deutschland that the company was in advanced talks for a contract worth more than Lion’s $125 million deal with Bayer.

“At the moment we are in discussions with companies. At least one of the deals could possibly be bigger than the Bayer deal,” von Bolen told the paper.

Lion spokeswoman Andrea Kreisselmeier confirmed the company was in negotiations with several companies and expects “one or two major deals by the end of the calendar year.”

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.